- Home
- KEN vs ARWR Comparison
KEN vs ARWR Comparison
Compare KEN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEN
- ARWR
- Stock Information
- Founded
- KEN 2014
- ARWR 2003
- Country
- KEN Singapore
- ARWR United States
- Employees
- KEN N/A
- ARWR N/A
- Industry
- KEN Electric Utilities: Central
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- KEN Utilities
- ARWR Health Care
- Exchange
- KEN Nasdaq
- ARWR Nasdaq
- Market Cap
- KEN 1.8B
- ARWR 1.8B
- IPO Year
- KEN N/A
- ARWR 1993
- Fundamental
- Price
- KEN $37.44
- ARWR $15.62
- Analyst Decision
- KEN
- ARWR Buy
- Analyst Count
- KEN 0
- ARWR 9
- Target Price
- KEN N/A
- ARWR $43.71
- AVG Volume (30 Days)
- KEN 16.8K
- ARWR 1.6M
- Earning Date
- KEN 05-28-2025
- ARWR 08-07-2025
- Dividend Yield
- KEN 13.30%
- ARWR N/A
- EPS Growth
- KEN N/A
- ARWR N/A
- EPS
- KEN 11.35
- ARWR N/A
- Revenue
- KEN $760,304,000.00
- ARWR $545,209,000.00
- Revenue This Year
- KEN N/A
- ARWR $21,924.50
- Revenue Next Year
- KEN N/A
- ARWR N/A
- P/E Ratio
- KEN $3.16
- ARWR N/A
- Revenue Growth
- KEN 5.78
- ARWR 1436.97
- 52 Week Low
- KEN $23.31
- ARWR $9.57
- 52 Week High
- KEN $37.50
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- KEN 65.81
- ARWR 45.97
- Support Level
- KEN $34.52
- ARWR $15.19
- Resistance Level
- KEN $36.60
- ARWR $16.06
- Average True Range (ATR)
- KEN 0.58
- ARWR 0.66
- MACD
- KEN -0.07
- ARWR -0.23
- Stochastic Oscillator
- KEN 89.60
- ARWR 3.25
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.